Bayer Bayer

This site is intended for US Healthcare Professionals Only

Welcome to the Pulmonary Hypertension Accelerated Bayer Awards website

Following the successful completion of the second year of the PHAB Awards program, we are delighted to announce that Letters of Intent (LOI) may be submitted to the program for the 2021 /2022 cycle. The deadline for submission of LOIs is 1st November 2021. For subsequent timelines click below and see section Dates and deadlines.

Find out More

To apply for the PHAB Awards

Follow our step-by-step instructions to discover how to submit a proposal.

Submit a Proposal

Submissions accepted now

Click the button below for more information.

View More

Welcome to the Pulmonary Hypertension Accelerated Bayer Awards website

Following the successful completion of the second year of the PHAB Awards program, we are delighted to announce that Letters of Intent (LOI) may be submitted to the program for the 2021/2022 cycle. The  deadline for submission of LOIs is 1st November 2021. For subsequent timelines click below and see section Dates and deadlines.

Find out More

To apply for the PHAB Awards

Follow our step-by-step instructions to discover how to submit a proposal.

Submit a Proposal

Submissions accepted now

Click the button below for more information.

View More

The program can collectively award a total of up to US$1 million in grants. The research project duration can extend over two years.

The PHAB Awards aim to support clinical research in pulmonary hypertension (PH) with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Applicants may include early-mid career investigators, fellows in training, and other PH healthcare professionals working in the USA. The objectives of the program are to:

  • Support continued advancement in PH science and care
  • Contribute to the continued growth of early-career scientists and clinicians involved in PH research
Learn more about the program

©2021 Bayer Corporation. All rights reserved

Last update: September 2021  PP-PF-PUL-US-0248-1

Bayer and the Bayer cross are registered trademarks of Bayer

Privacy Statement | Conditions of Use | California Transparency in Supply Chains

Bayer
Bayer

©2020 Bayer Corporation. All rights reserved.

Last update: November 2020 PP-ADE-US-1897

Privacy Statement | Conditions of Use | California Transparency in Supply Chains